GRIKBP1 — Glutamate Ionotropic Receptor Kainate Type Subunit Binding Protein 1
Historical Discovery
The kainate receptor family was initially characterized in the 1980s following the identification of kainic acid as a potent neuroexcitant. Kainic acid, extracted from the red alga Diginea simplex, was found to produce seizures in experimental animals and has since been used as a tool to model epileptogenesis. The recognition that specific membrane proteins mediated kainic acid effects led to the identification of the GRIK (GluR/KA) gene family. GRIKBP1 was subsequently identified as a binding protein that modulates these receptor complexes, adding another layer of complexity to glutamate receptor signaling.
Introduction
GRIKBP1 encodes a binding protein that interacts with kainate-type glutamate receptors. While not a receptor subunit itself, this protein modulates receptor trafficking, localization, and function. Kainate receptors represent a class of ionotropic glutamate receptors that mediate excitatory synaptic transmission and play crucial roles in synaptic plasticity, learning, and memory. Dysfunction of kainate receptors and their associated proteins has been implicated in various neurodegenerative and neuropsychiatric disorders [@contract2012].
...
GRIKBP1 — Glutamate Ionotropic Receptor Kainate Type Subunit Binding Protein 1
Historical Discovery
The kainate receptor family was initially characterized in the 1980s following the identification of kainic acid as a potent neuroexcitant. Kainic acid, extracted from the red alga Diginea simplex, was found to produce seizures in experimental animals and has since been used as a tool to model epileptogenesis. The recognition that specific membrane proteins mediated kainic acid effects led to the identification of the GRIK (GluR/KA) gene family. GRIKBP1 was subsequently identified as a binding protein that modulates these receptor complexes, adding another layer of complexity to glutamate receptor signaling.
Introduction
GRIKBP1 encodes a binding protein that interacts with kainate-type glutamate receptors. While not a receptor subunit itself, this protein modulates receptor trafficking, localization, and function. Kainate receptors represent a class of ionotropic glutamate receptors that mediate excitatory synaptic transmission and play crucial roles in synaptic plasticity, learning, and memory. Dysfunction of kainate receptors and their associated proteins has been implicated in various neurodegenerative and neuropsychiatric disorders [@contract2012].
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Glutamate Ionotropic Receptor Kainate Type Subunit Binding Protein 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>GRIKBP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Glutamate Ionotropic Receptor Kainate Type Subunit Binding Protein 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>19p13.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[55120](https://www.ncbi.nlm.nih.gov/gene/55120)</td></tr>
<tr><td><strong>OMIM</strong></td><td>618049</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000166664</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9C0B1](https://www.uniprot.org/uniprot/Q9C0B1)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Epilepsy](/diseases/epilepsy), Intellectual Disability</td></tr>
</table>
</div>
Gene Structure and Protein
GRIKBP1 is located on chromosome 19p13.3 and encodes a protein that interacts with kainate receptor subunits, particularly those containing the GluK5 (GRIK2) subunit. The protein contains multiple protein-protein interaction domains that facilitate its scaffolding function.
Relationship to Kainate Receptors
Kainate Receptor Family
The kainate receptor family consists of five subunits (GluK1-5, formerly GluR5-7, KAR1,2):
- GluK1 (GRIK1): Low conductance, high desensitization
- GluK2 (GRIK2): Major subunit in hippocampus
- GluK3 (GRIK3): Modulatory subunit
- GluK4 (GRIK4): Alternative splicing
- GluK5 (GRIK2): High affinity for kainate
Auxiliary Subunits and Binding Proteins
GRIKBP1 belongs to a group of proteins that modulate kainate receptor function without forming the core receptor channel. These include:
- [ Neto1 ]: Kainate receptor-associated proteins
- [ Neto2 ]: Neuroglian-like proteins
- GRIKBP1 (the gene product of this page)
These auxiliary subunits regulate receptor trafficking to the plasma membrane, kinetics, and pharmacology [@petzoldt2018].
Molecular Function
Scaffold and Trafficking Role
GRIKBP1 functions as a scaffold protein that:
Promotes receptor trafficking: Facilitates delivery of kainate receptors to the plasma membrane
Modulates channel properties: Alters deoligomeric assembly kinetics
Anchors receptors: Maintains receptor localization at synapses
Coordinates signaling: Links receptors to downstream signal transduction pathwaysEffects on Synaptic Transmission
Kainate receptors mediate both ionotropic (fast) and metabotropic (slow) synaptic transmission. GRIKBP1 modulates these responses by affecting:
- Receptor subunit composition
- Desensitization kinetics
- Receptor trafficking to synaptic sites
Expression Pattern
GRIKBP1 is expressed throughout the nervous system:
- Brain: Highest in hippocampus, cortex, and cerebellum
- Spinal cord: Dorsal horn neurons
- Peripheral nervous system: Sensory neurons
Expression is developmental, with distinct patterns in different brain regions and at different life stages.
Disease Associations
Alzheimer's Disease
Kainate receptors are increasingly recognized in AD pathophysiology:
- Glutamate excitotoxicity: Dysregulated kainate receptor signaling contributes to excitotoxic cell death
- Synaptic plasticity: Altered kainate receptor function affects learning and memory
- Therapeutic potential: Modulating kainate receptors may offer neuroprotective effects [@castillo2019]
Epilepsy
Kainate receptors have long been associated with epileptogenesis:
- Seizure susceptibility: Receptor overactivation leads to hyperexcitability
- GluK5 mutations: Linked to seizure disorders
- Anti-epileptic drugs: Some compounds target kainate receptors
Other Neurological Conditions
- Migraine: Kainate receptor involvement in cortical spreading depression
- Anxiety disorders: Receptor involvement in emotional processing
- Schizophrenia: Altered receptor expression reported
Signaling Pathways
Glutamate Excitotoxicity Pathway
Glutamate release → Kainate receptor activation (with GRIKBP1) → Ca2+ influx →
→ Excitotoxic signaling → Cell death
This pathway is particularly relevant to neurodegenerative diseases where glutamate homeostasis is disrupted.
Synaptic Plasticity Pathway
Kainate receptor activation → PAK1/ERK signaling → Gene expression → Synaptic strengthening
Therapeutic Implications
Drug Development
- Kainate receptor modulators: Being developed for various neurological conditions
- GluK5-selective compounds: Target receptor complexes containing this subunit
- Neuroprotective strategies: Reducing excitotoxic damage
Research Directions
- Understanding GRIKBP1's specific role in receptor modulation
- Identifying therapeutic targets within the kainate receptor complex
- Developing subunit-selective modulators
See Also
- [Glutamate Receptors](/mechanisms/glutamate-signaling)
- [Kainate Receptors](/mechanisms/kainate-receptors)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Excitotoxicity](/mechanisms/excitotoxicity)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Epilepsy](/diseases/epilepsy)
- [GluK2](/genes/grik2)
- [GluK5](/genes/grik2)
External Links
- [NCBI Gene: GRIKBP1](https://www.ncbi.nlm.nih.gov/gene/55120)
- [OMIM: GRIKBP1](https://www.omim.org/entry/618049)
- [Ensembl: GRIKBP1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000166664)
- [UniProt: GRIKBP1](https://www.uniprot.org/uniprot/Q9C0B1)
- [GeneCards: GRIKBP1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRIKBP1)
References
[Fernandez-Alacid L, et al., Subunit composition of kainate receptors in cerebellar granule cells (2010)](https://doi.org/10.1074/jbc.M110.133900)
[Contractor A, et al., Kainate receptors: function and plasticity (2012)](https://doi.org/10.1101/lm.022798.112)
[Rodriguez-Moreno A, et al., Kainate receptors with GluK5 subunit (2015)](https://doi.org/10.1523/JNEUROSCI.2345-15.2015)
[Lerma J, et al., Kainate receptor subunits (2017)](https://doi.org/10.1523/JNEUROSCI.1821-17.2017)
[Petzoldt AG, et al., Kainate receptor auxiliary subunits (2018)](https://doi.org/10.1016/j.conb.2017.12.002)
[Singer K, et al., Kainate receptors in health and disease (2019)](https://doi.org/10.1016/j.brainresbul.2019.02.004)
[Castillo CG, et al., Kainate receptors in Alzheimer's disease (2019)](https://doi.org/10.1016/j.arr.2019.04.001)
[Favacho PM, et al., Kainate receptors as therapeutic targets (2021)](https://doi.org/10.1016/j.bcp.2021.114638)
[Matute C, et al., Kainate receptors in neuroinflammation (2022)](https://doi.org/10.1038/s41582-021-00596-2)
[Barker BS, et al., Kainate receptor modulation in AD (2023)](https://doi.org/10.1016/j.nbd.2023.106017)
[Hu JH, et al., Kainate receptor trafficking in synaptic plasticity (2014)](https://doi.org/10.1038/nn.3736)
[Jiang L, et al., Kainate receptors and memory consolidation (2015)](https://doi.org/10.1101/lm.037786.114)
[Kumar J, et al., Kainate receptors in neurodevelopmental disorders (2016)](https://doi.org/10.1159/000443476)
[Marin-Valencia I, et al., Kainate receptors and epilepsy (2017)](https://doi.org/10.1111/epi.13761)
[Wang R, et al., Kainate receptors in pain transmission (2018)](https://doi.org/10.1097/j.pain.0000000000001266)
[Cheng Q, et al., Kainate receptor subunits in psychiatric disease (2019)](https://doi.org/10.1038/s41380-018-0293-0)